BESONG, GILBERT,LU, YIPIN,MORTENSON, PAUL,SMITH, TROY,SUNG, MOO,WOODHEAD, STEVEN,WRONA, WOJCIECH,BHARAT LAGU,BRAIN, CHRISTOPHER THOMAS,BROOKS, CLINTON A.,CONGREVE, MILES STUART,DAGOSTIN, CLAUDIO,HE, G
申请号：
MYPI 2011000681
公开号：
MY150560A
申请日:
2009.08.20
申请国别(地区):
MY
年份:
2014
代理人:
摘要：
THE DISCLOSED COMPOUNDS RELATE TO TREATMENTS AND THERAPIES FOR PROTEIN KINASE-ASSOCIATED DISORDERS.THERE IS ALSO A NEED FOR COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OR AMELIORATION OF ONE OR MORE SYMPTOMS OF CANCER, TRANSPLANT REJECTIONS, AND AUTOIMMUNE DISEASES. FURTHERMORE, THERE IS A NEED FOR METHODS FOR MODULATING THE ACTIVITY OF PROTEIN KINASES, SUCH AS CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 AND CDK9, USING THE COMPOUNDS PROVIDED HEREIN.
